<DOC>
	<DOCNO>NCT02444000</DOCNO>
	<brief_summary>Patients 1p/19q-codeleted anaplastic glioma treat RT + PCV risk neurocognitive deterioration . Treating patient PCV alone ( could reduce risk neurocognitive deterioration without impair overall survival .</brief_summary>
	<brief_title>gliomasPCV Only 1p/19q Codeleted Anaplastic Gliomas</brief_title>
	<detailed_description>Multicentric , Randomized phase III study ( 1:1 ) , Population : newly diagnose 1p/19-codeleted anaplastic glioma , Primary objective : To determine whether treat newly diagnose 1p/19q-codeleted anaplastic glioma PCV alone increase overall survival without neurocognitive deterioration Control group : radiotherapy follow 6 cycle PCV chemotherapy . Experimental group : 6 cycle PCV chemotherapy ( radiotherapy defer time progression ) . Number centre participate : 31 center POLA network Recruitment duration : 7 year , accrual rate 40 patient per year , patient followed-up end trial .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Procarbazine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Inclusion criterion : Histological confirmation anaplastic glioma central pathological review Tumor codeleted 1p 19q Age ≥ 18 year age Newly diagnose ≤3 month surgical diagnosis Willing able complete neurocognitive examination QOL Karnofsky performance status ≥ 60 The following laboratory value obtain ≤ 21 day prior registration : Absolute neutrophil count ( ANC ) ≥1500 /mm3 Platelet count ≥100,000 / mm3 Hemoglobin &gt; 9.0 g/dL Total bilirubin ≤ 1.5 x upper limit normal ( ULN ) SGOT ( AST ) ≤ 3 x ULN Negative serum urine pregnancy test do ≤ 7 day prior registration , woman childbearing potential . Provide inform write consent Exclusion criterion : Pregnant nursing woman Men woman childbearing potential unwilling employ adequate contraception study 6 month follow completion PCV . Received prior radiation therapy chemotherapy CNS neoplasm .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>chemotherapy</keyword>
	<keyword>PCV</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>post operative treatment</keyword>
	<keyword>anaplastic glioma</keyword>
	<keyword>1p/19q codeletion</keyword>
	<keyword>cognition</keyword>
</DOC>